Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jia-Feng Chen

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Journal of Oncology|November 21, 2022
Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and ChallengesAo Huang, Jia-Feng Chen, Jian-Zhang Wu, et al.
Cell Death & Disease|February 9, 2022
Targeted activation of androgen receptor signaling in the periosteum improves bone fracture repairKuo-Chung Lan, Kuo-Ting Wei, Pei-Wen Lin, et al.
Cancer Cell International|March 20, 2022
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinomaZheng Gao, Jia-Feng Chen, Xiao-Gang Li, et al.
Zhonghua Yi Xue Za Zhi|July 26, 2007
[A multiple center study on depression and anxiety state in the department of neurology]Jing Zhang, Jing Wei, Li-li Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 20, 2023
Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitmentZheng Gao, Shan-Ru Feng, Jia-Feng Chen, et al.
International Immunopharmacology|July 26, 2023
Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinomaZheng Gao, Xiao-Gang Li, Shan-Ru Feng, et al.
International Journal of Biological Macromolecules|July 29, 2024
Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammationXiu-Tao Fu, Jing-Bo Qie, Jia-Feng Chen, et al.
Science Advances|May 2, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8<sup>+</sup> T cell function and inhibiting tumor growth in hepatocellular carcinomaWei-Feng Qu, Gui-Qi Zhu, Rui Yang, et al.
Experimental Hematology & Oncology|June 17, 2026
Autophagy-promoted immunogenic cell death elicited by tyrosine kinase inhibitor orchestrates a synergistic immunotherapeutic microenvironment in hepatocellular carcinomaShan-Ru Feng, En-Fu Dong, Zheng Gao, et al.
Hepatology International|April 8, 2023
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantationWei-Feng Qu, Meng-Xin Tian, Hong-Wei Lu, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Journal of Oncology|November 21, 2022
Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and ChallengesAo Huang, Jia-Feng Chen, Jian-Zhang Wu, et al.
Cell Death & Disease|February 9, 2022
Targeted activation of androgen receptor signaling in the periosteum improves bone fracture repairKuo-Chung Lan, Kuo-Ting Wei, Pei-Wen Lin, et al.
Cancer Cell International|March 20, 2022
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinomaZheng Gao, Jia-Feng Chen, Xiao-Gang Li, et al.
Zhonghua Yi Xue Za Zhi|July 26, 2007
[A multiple center study on depression and anxiety state in the department of neurology]Jing Zhang, Jing Wei, Li-li Shi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 20, 2023
Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitmentZheng Gao, Shan-Ru Feng, Jia-Feng Chen, et al.
International Immunopharmacology|July 26, 2023
Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinomaZheng Gao, Xiao-Gang Li, Shan-Ru Feng, et al.
International Journal of Biological Macromolecules|July 29, 2024
Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammationXiu-Tao Fu, Jing-Bo Qie, Jia-Feng Chen, et al.
Science Advances|May 2, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8<sup>+</sup> T cell function and inhibiting tumor growth in hepatocellular carcinomaWei-Feng Qu, Gui-Qi Zhu, Rui Yang, et al.
Experimental Hematology & Oncology|June 17, 2026
Autophagy-promoted immunogenic cell death elicited by tyrosine kinase inhibitor orchestrates a synergistic immunotherapeutic microenvironment in hepatocellular carcinomaShan-Ru Feng, En-Fu Dong, Zheng Gao, et al.
Hepatology International|April 8, 2023
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantationWei-Feng Qu, Meng-Xin Tian, Hong-Wei Lu, et al.
Pageof 8